RecruitingMultiple MyelomaAmyloidosisPlasma Cell Leukemia
Cancer and Aging Resilience Evaluation in Older Adults With Hematologic Malignancies: The CARE-Heme Registry
Eligible age
50+ yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The primary purpose of this protocol is to create a registry of older (≥50 years old) patients with Hematologic Malignancies. Our main objectives include: To understand the prevalence of frailty and geriatric impairments among patients aged ≥50y and above diagnosed with a hematologic malignancy at UAB and to gather information that would lend support for future research in this vulnerable population.
Sponsor: University of Alabama at Birmingham
You may qualify if…
- ✓ Patients are ≥50 years of age.
- ✓ Patients have a biopsy proven diagnosis of Hematologic Malignancy (Multiple Myeloma, AL Amyloidosis, Waldenstrom's Macrogloblunemia, Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Myelodysplastic syndromes, Myeloproliferative Neoplasm, Acute/Chronic Myeloid Leukemia, Acute/Chronic Lymphoid Leukemia).
- ✓ Patients have appointments at UAB including if they are an inpatient or other clinic locations.
You may not qualify if…
- ✕ Individuals who are \<50 years old.
- ✕ Patients who do not read and/or speak English will not be eligible for this study as many of the questionnaires are not validated in other languages. No exclusions will be made based on gender, ethnicity or race.
Where it's recruiting
Alabama
Birmingham
Source: ClinicalTrials.gov · NCT05556928 · last updated 2025-12-08